Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6146047, 11 pages
http://dx.doi.org/10.1155/2016/6146047
Research Article

Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research

1Clinic for Plastic and Hand Surgery, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Clinic for Hematology, Oncology and Stem Cell Transplantation, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
3Institute of Anatomy and Cell Biology, University of Freiburg, Freiburg, Germany
4Institute for Environmental Health Sciences and Hospital Infection Control, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany

Received 5 November 2015; Revised 31 January 2016; Accepted 15 February 2016

Academic Editor: Yanfang Chen

Copyright © 2016 A. Fricke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Herzog, “Overview of sarcomas in the adolescent and young adult population,” Journal of Pediatric Hematology/Oncology, vol. 27, no. 4, pp. 215–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. F. C. Eilber and S. M. Dry, “Diagnosis and management of synovial sarcoma,” Journal of Surgical Oncology, vol. 97, no. 4, pp. 314–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Crew, J. Clark, C. Fisher et al., “Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma,” The EMBO Journal, vol. 14, no. 10, pp. 2333–2340, 1995. View at Google Scholar · View at Scopus
  4. J. Clark, P. J. Rocques, A. J. Crew et al., “Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma,” Nature Genetics, vol. 7, no. 4, pp. 502–508, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Skytting, G. Nilsson, B. Brodin et al., “A novel fusion gene, SYT-SSX4, in synovial sarcoma,” Journal of the National Cancer Institute, vol. 91, no. 11, pp. 974–975, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Kadoch and G. R. Crabtree, “Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma,” Cell, vol. 153, no. 1, pp. 71–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. O. Nielsen, N. M. Poulin, and M. Ladanyi, “Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy,” Cancer Discovery, vol. 5, no. 2, pp. 124–134, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Haldar, J. D. Hancock, C. M. Coffin, S. L. Lessnick, and M. R. Capecchi, “A conditional mouse model of synovial sarcoma: insights into a myogenic origin,” Cancer Cell, vol. 11, no. 4, pp. 375–388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ladanyi and J. A. Bridge, “Contribution of molecular genetic data to the classification of sarcomas,” Human Pathology, vol. 31, no. 5, pp. 532–538, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kawai, J. Woodruff, J. H. Healey, M. F. Brennan, C. R. Antonescu, and M. Ladanyi, “SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma,” The New England Journal of Medicine, vol. 338, no. 3, pp. 153–160, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kubo, S. Shimose, J. Fujimori, T. Furuta, and M. Ochi, “Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis,” SpringerPlus, vol. 4, article 375, 2015. View at Publisher · View at Google Scholar
  12. T. Ren, Q. Lu, W. Guo et al., “The clinical implication of SS18-SSX fusion gene in synovial sarcoma,” British Journal of Cancer, vol. 109, no. 8, pp. 2279–2285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Skog, T. Würdinger, S. van Rijn et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nature Cell Biology, vol. 10, no. 12, pp. 1470–1476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Xie, M. Törnkvist, Y. Aalto et al., “Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene,” Oncogene, vol. 22, no. 48, pp. 7628–7631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Eitan, S. Zhang, K. W. Witwer, and M. P. Mattson, “Extracellular vesicle–depleted fetal bovine and human sera have reduced capacity to support cell growth,” Journal of Extracellular Vesicles, vol. 4, Article ID 26373, 2015. View at Publisher · View at Google Scholar
  16. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Hellwig, A. Masuch, S. Nestel, N. Katzmarski, M. Meyer-Luehmann, and K. Biber, “Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures,” Scientific Reports, vol. 5, Article ID 14624, 2015. View at Publisher · View at Google Scholar
  18. D. Ferreira Barreto-Vieira and O. M. Barth, “Negative and positive staining in transmission electron microscopy for virus diagnosis,” in Microbiology in Agriculture and Human Health, M. M. Shah, Ed., InTech, 2015. View at Publisher · View at Google Scholar
  19. A. Keller, P. Leidinger, A. Bauer et al., “Toward the blood-borne miRNome of human diseases,” Nature Methods, vol. 8, no. 10, pp. 841–843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Hashimoto, A. Myoui, N. Araki et al., “Detection of SYT-SSX fusion gene in peripheral blood from a patient with synovial sarcoma,” The American Journal of Surgical Pathology, vol. 25, no. 3, pp. 406–410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Fricke, P. V. Ullrich, J. Heinz et al., “Identification of a blood-borne miRNA signature of synovial sarcoma,” Molecular Cancer, vol. 14, article 151, 2015. View at Publisher · View at Google Scholar
  22. M. Hisaoka, A. Matsuyama, Y. Nagao et al., “Identification of altered MicroRNA expression patterns in synovial sarcoma,” Genes Chromosomes and Cancer, vol. 50, no. 3, pp. 137–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Baj-Krzyworzeka, R. Szatanek, K. Węglarczyk et al., “Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes,” Cancer Immunology, Immunotherapy, vol. 55, no. 7, pp. 808–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Andreola, L. Rivoltini, C. Castelli et al., “Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles,” Journal of Experimental Medicine, vol. 195, no. 10, pp. 1303–1316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Barz, M. Goppelt, M. Szamel, V. Schirrmacher, and K. Resch, “Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb),” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 814, no. 1, pp. 77–84, 1985. View at Publisher · View at Google Scholar · View at Scopus
  26. M. F. C. Amary, F. Berisha, F. D. C. Bernardi et al., “Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma,” Modern Pathology, vol. 20, no. 4, pp. 482–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Drandi, L. Kubiczkova-Besse, S. Ferrero et al., “Minimal residual disease detection by droplet digital pcr in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR,” The Journal of Molecular Diagnostics, vol. 17, no. 6, pp. 652–660, 2015. View at Publisher · View at Google Scholar
  28. G. Fontanelli, C. Baratè, E. Ciabatti et al., “Real-time PCR and droplet digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms,” International Journal of Laboratory Hematology, vol. 37, no. 6, pp. 766–773, 2015. View at Publisher · View at Google Scholar
  29. R. T. Hayden, Z. Gu, J. Ingersoll et al., “Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus,” Journal of Clinical Microbiology, vol. 51, no. 2, pp. 540–546, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kiselinova, A. O. Pasternak, W. De Spiegelaere, D. Vogelaers, B. Berkhout, and L. Vandekerckhove, “Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA,” PLoS ONE, vol. 9, no. 1, Article ID e85999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Miyachi, K. Tsuchiya, H. Yoshida et al., “Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma,” Biochemical and Biophysical Research Communications, vol. 400, no. 1, pp. 89–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Sieuwerts, J. Kraan, J. Bolt et al., “Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells,” Journal of the National Cancer Institute, vol. 101, no. 1, pp. 61–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. W. J. Allard, J. Matera, M. C. Miller et al., “Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases,” Clinical Cancer Research, vol. 10, no. 20, pp. 6897–6904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-M. Hou, A. Greystoke, L. Lancashire et al., “Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy,” The American Journal of Pathology, vol. 175, no. 2, pp. 808–816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. F. Hayes, M. Cristofanilli, G. T. Budd et al., “Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival,” Clinical Cancer Research, vol. 12, no. 14, part 1, pp. 4218–4224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Satelli, A. Mitra, J. J. Cutrera et al., “Universal marker and detection tool for human sarcoma circulating tumor cells,” Cancer Research, vol. 74, no. 6, pp. 1645–1650, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-H. Kitamura, A. Shirahata, M. Sakata et al., “Frequent methylation of Vimentin in well-differentiated gastric carcinoma,” Anticancer Research, vol. 29, no. 6, pp. 2227–2229, 2009. View at Google Scholar · View at Scopus
  38. M. Li, B. Zhang, X. Wang et al., “A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis,” Journal of Experimental and Clinical Cancer Research, vol. 29, article 109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Schleiermacher, M. Peter, O. Oberlin et al., “Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor,” Journal of Clinical Oncology, vol. 21, no. 1, pp. 85–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. D. C. West, H. E. Grier, M. M. Swallow, G. D. Demetri, L. Granowetter, and J. Sklar, “Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor,” Journal of Clinical Oncology, vol. 15, no. 2, pp. 583–588, 1997. View at Google Scholar · View at Scopus
  41. E. de Alava, M. D. Lozano, A. Patiño, L. Sierrasesúmaga, and F. J. Pardo-Mindán, “Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples,” Diagnostic Molecular Pathology, vol. 7, no. 3, pp. 152–157, 1998. View at Publisher · View at Google Scholar
  42. K. M. Kelly, R. B. Womer, and F. G. Barr, “Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method,” Cancer, vol. 78, no. 6, pp. 1320–1327, 1996. View at Google Scholar · View at Scopus
  43. M. Hoshino, A. Ogose, H. Kawashima et al., “Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma,” Cancer Genetics and Cytogenetics, vol. 190, no. 2, pp. 75–80, 2009. View at Publisher · View at Google Scholar · View at Scopus